Morphea
☆ Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Isilonda se Morphea sikholisa ukuvela njenge patch ene-atrophic pigmented.
References
Scleroderma sisifo esinqabileyo esichaphazela izicubu ezixhumeneyo, ezibonisa ulusu oluqinileyo kwaye ngamanye amaxesha luchaphazela amanye amalungu omzimba. Kukho iindidi ezimbini eziphambili: systemic sclerosis , ebandakanya ukuqina kwesikhumba kunye namalungu angaphakathi, kwaye localized scleroderma , ekwaziwa ngokuba yi-morphea, ehlala ilinganiselwe eluswini nakwizicubu ezingaphantsi kwayo, kunye nekhosi enobungozi kunye nokuzibekela umda. Nangona i-scleroderma yendawo ingaqhelekanga kwaye imbangela yayo ayicacanga, uphando lwakutsha nje lubonisa ukuba inokuchaphazela izitho zangaphakathi kwaye ikhokelele kwimicimbi eyahlukeneyo yezempilo. Unyango lwakwangoko lubalulekile ukunqanda iingxaki, xa kujongwa ubunzulu obunokubakho be- localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea , ekwabizwa ngokuba yi-localized scleroderma, sisifo esinqabileyo sokuzikhusela komzimba esichaphazela izicubu ezixhumeneyo. Inokuvela ngeendlela ezahlukeneyo, kwaye ayiqhelekanga kakhulu, malunga ne- 0. 4 - 2. 7 iimeko ngabantu abayi-100,000 ngonyaka ngamnye. Morphea idla ngokubonwa kubantwana abaphakathi kweminyaka emi-2 kunye ne-14 ubudala, kwaye idla ngokuchaphazela amantombazana rhoqo kunamakhwenkwe.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
I-Morphea sisifo esinqabileyo kakhulu. Ngenxa yokwakheka kwefoto, i-algorithm inokuba iyenze impazamo nge morphea.